Etanercept In Juvenile Idiopathic Arthritis - R... -

Since its FDA approval in 1999, (Enbrel) has served as a cornerstone biologic therapy for children with Juvenile Idiopathic Arthritis (JIA) who do not respond sufficiently to standard treatments like methotrexate. Clinical Effectiveness Across JIA Subtypes

Etanercept is a TNF-alpha inhibitor that works by blocking inflammatory proteins to reduce joint swelling and pain.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .